Healthcare Resource Utilisation and Costs of Treating NSAID-Associated Gastrointestinal Toxicity
- 1 January 2001
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 19 (1) , 17-32
- https://doi.org/10.2165/00019053-200119001-00002
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Resource costing for multinational neurologic clinical trials: methods and resultsHealth Economics, 1998
- Epidemiology of Nonsteroidal Anti-inflammatory Drug–Associated Gastrointestinal InjuryThe American Journal of Medicine, 1998
- Clinical economics review: gastrointestinal complications of non-steroidal anti-inflammatory drugsAlimentary Pharmacology & Therapeutics, 1998
- Management of NSAID-induced gastropathy: an economic decision analysisClinical Therapeutics, 1997
- THE RISKS AND COSTS OF UPPER GASTROINTESTINAL DISEASE ATTRIBUTABLE TO NSAIDSGastroenterology Clinics of North America, 1996
- The iatrogenic cost of non-steroidal anti-inflammatory drug therapyRheumatology, 1995
- The cost‐effectiveness of misoprostol for nonsteroidal antiinflammatory drug–associated adverse gastrointestinal eventsArthritis & Rheumatism, 1993
- Economic evaluation of gastric ulcer prophylaxis in patients with arthritis receiving non-steroidal anti-inflammatory drugsPublished by Oxford University Press (OUP) ,1990
- Direct medical costs of disease and gastrointestinal side effects during treatment for arthritisThe American Journal of Medicine, 1988